Point of controversy: Perioperative care of patients undergoing pheochromocytoma removal-time for a reappraisal?

European Journal of Endocrinology

Volumn 165, Issue 3, 2011, Pages 365-373

  Lentschener, Claude ^a   Gaujoux, Sebastien ^a   Tesniere, Antoine ^a   Dousset, Bertrand ^a  

^a Université Paris Descartes ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; ATRACURIUM; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DESFLURANE; DOXAZOSIN; ESMOLOL; GLYCERYL TRINITRATE; ISOFLURANE; KETAMINE; LIDOCAINE; MAGNESIUM SULFATE; METIROSINE; METOPROLOL; NICARDIPINE; NITROPRUSSIDE SODIUM; NITROUS OXIDE; PHENOXYBENZAMINE; PHENTOLAMINE; PRAZOSIN; PROPRANOLOL; SEVOFLURANE; SUXAMETHONIUM; TERAZOSIN; TUBOCURARINE CHLORIDE; UNINDEXED DRUG; URAPIDIL; VASOACTIVE AGENT; VECURONIUM; LABETALOL;

ADRENALECTOMY; ANESTHESIOLOGICAL TECHNIQUES; CANCER SURGERY; CONTINUOUS INFUSION; DRUG HALF LIFE; DRUG MEGADOSE; FLUID THERAPY; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOVOLEMIA; INTRAOPERATIVE PERIOD; NOSE CONGESTION; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PHEOCHROMOCYTOMA; PREOPERATIVE CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SOMNOLENCE; SURGICAL MORTALITY; SURGICAL PATIENT; SURGICAL TECHNIQUE; SYNCOPE; TACHYCARDIA; ANESTHESIA INDUCTION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG MECHANISM; HEMODYNAMICS; HYPOTENSION; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREDICTION; PREGNANCY; SYSTOLIC BLOOD PRESSURE; TUMOR VOLUME; ADRENAL TUMOR; FEMALE; PEROPERATIVE CARE; PREGNANCY COMPLICATION;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; FEMALE; HUMANS; HYPERTENSION; INTRAOPERATIVE CARE; PERIOPERATIVE CARE; PHEOCHROMOCYTOMA; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 80051704347     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0162     Document Type: Review

References (63)

1. Guerrero MA, Schreinemakers JM, Vriens MR, Suh I, Hwang J, Shen WT, Gosnell J, Clark OH & Duh QY. Clinical spectrum of pheochromocytoma. Journal of the American College of Surgeons 2009 209 727-732. (doi:10.1016/j. jamcollsurg.2009.09.022)
2. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS & Eisenhofer G. Biochemical diagnosis of pheochromocytoma: which test is best? Journal of the American Medical Association 2002 20 1427-1434. (doi:10.1001/jama.287.11.1427)
3. Kopetschke R, Slisko M, Kilisli A, Tuschy U, Wallaschofski H, Fassnacht M, Ventz M, Beuschlein F, Reincke M, Reisch N &Quinkler M. Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. European Journal of Endocrinology 2009 161 355-361. (doi:10.1530/EJE-09-0384)
4. Opocher G & Schiavi F. Genetics of pheochromocytomas and paragangliomas. Best Practice and Research. Clinical Endocrinology and Metabolism 2010 24 943-956. (doi:10.1016/j.beem.2010.05.001)
5. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM & Tischler AS. International symposium on pheochromocytoma. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nature Clinical Practice. Endocrinology & Metabolism 2007 3 92-102. (doi:10.1038/ ncpendmet0396)
6. Jude EB & Sridhar CB. Prolonged hypoglycaemia following surgical removal of phaeochromocytoma. Postgraduate Medical Journal 2000 76 39-40. (doi:10.1136/pmj.76.891.39)
7. Levin H & Heifetz M. Phaeochromocytoma and severe protracted postoperative hypoglycaemia. Canadian Journal of Anaesthesia 1990 37 477-478. (doi:10.1007/BF03005631)
8. Proye C, Fossati P, Fontaine P, Lefebvre J, Decoulx M, Wemeau JL, Dewailly D, Rwamasirabo E & Cecat P. Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery 1986 100 1154-1162. (Pubitemid 17223236)
9. Brukamp K, Goral S, Townsend RR, Silvestry FE & Torigian DA. Rapidly reversible cardiogenic shock as a pheochromocytoma presentation. American Journal of Medicine 2007 120 1-2. (doi:10.1016/j.amjmed.2006.08.031)
10. Pace DE, Chiasson PM, Schlachta CM, Mamazza J, Cadeddu MO &Poulin EC. Minimally invasive adrenalectomy for pheochromocytoma during pregnancy. Surgical Laparoscopy, Endoscopy &Percutaneous Techniques 2002 2 122-125. (doi:10.1097/00129689-200204000-00011)
11. Toniato A, Boschin IM, Opocher G, Guolo A, Pelizzo M &Mantero F. Is the laparoscopic adrenalectomy for pheochromocytoma the best treatment? Surgery 2007 141 723-727. (doi:10.1016/j.surg.2006.10.012)
12. Kercher KW, Novitsky YW, Park A, Matthews BD, Litwin DE &Heniford BT. Laparoscopic curative resection of pheochromocytomas. Annals of Surgery 2005 241 919-926. (doi:10.1097/01.sla.0000164175.26785.06)
13. Ross EJ, Prichard BNC, Kaufman L, Robertson AIG & Harries BJ. Preoperative and operative management of patientswith pheochromocytoma. BMJ 19671191-198. (doi:10.1136/bmj.1.5534.191)
14. Thompson JE & Arrowod JG. Pheochromocytoma: surgical and anesthetic management. Anesthesiology 1954 15 658-665. (doi:10.1097/00000542-195411000- 00009)
15. Brunjes S, Johns VJ & Crane MG. Pheochromocytoma. Postoperative shock and blood volume. British Journal of Anaesthesia 1960 262 393-396.
16. Desmonts JM & Marty J. Anaesthetic management of patients with phaeochromocytoma. British Journal of Anaesthesia 1984 56 781-789. (doi:10.1093/bja/56.7.781)
17. Weingarten TN, Cata JP, O'Hara JF, Prybilla DJ, Pike TL, Thompson GB, Grant CS, Warner DO, Bravo E & Sprung J. Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. Urology 2010 76 508-511. (doi:10.1016/j.urology.2010.03.032)
18. Lebuffe G, Dosseh ED, Tek G, Tytgat H, Moreno S, Tavernier B, Vallet B & Proye CA. The effect of calcium channel blockers on outcome following the surgical treatment of pheochromocytomas and paragangliomas. Anaesthesia 2005 60 439-444. (doi:10.1111/j.1365-2044.2005.04156.x)
19. Chapman N, Chen CY, Fujita T, Hobbs FD, Kim SJ, Staessen JA, Tanomsup S, Wang JG, Cubeddu LX, Zarate NA, Rosales CB &Zschaeck DW. Prazosin and propranolol in preoperative management of pheochromocytoma. Clinical Pharmacology and Therapeutics 1982 32 156-160. (doi:10.1038/clpt.1982.141)
20. Goldfein A. Pheochromocytome: diagnosis and anesthetic and surgical management. Anesthesiology 1963 24 462-471. (doi:10.1097/00000542-196307000- 00008)
21. Goldstein RE, O'Neill JA Jr, Holcomb GW III, Morgan WM III, Neblett WW III, Oates JA, Brown N, Nadeau J, Smith B, Page DL, Abumrad NN & Scott HW Jr. Clinical experience over 48 years with pheochromocytoma. Annals of Surgery 1999 229 755-764. (doi:10.1097/00000658-199906000-00001)
22. Gosse P, Tauzin-Fin P, Sesay M-B, Sautereau A & Ballanger P. Preparation for surgery of phaeochromocytoma by blockade of a-adrenergic receptors with urapidil: what dose? Journal of Human Hypertension 2009 23 1-5. (doi:10.1038/jhh.2008.172)
23. James MF. Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma: a review of 17 anaesthetics. British Journal of Anaesthesia 1989 62 616-623. (doi:10.1093/bja/62.6.616)
24. Perry LB & Gould AB Jr. The anesthetic management of pheochromocytoma effect of preoperative adrenergic blocking drugs. Anesthesia and Analgesia 1972 51 36-40. (doi:10.1213/00000539-197201000-00010)
25. Plouin PF, Duclos JM, Soppelsa F, Boublil G & Chatellier G. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. Journal of Clinical Endocrinology and Metabolism 2001 86 1480-1486. (doi:10.1210/jc.86.4. 1480)
26. Poopalalingam R & Chin EY. Rapid preparation of a patient with pheochromocytoma with labetalol and magnesium sulfate. Canadian Journal of Anaesthesia 2001 48 876-880. (doi:10.1007/BF03017353)
27. Prys-Roberts C & Farndon JR. Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World Journal of Surgery 2002 26 1037-1042. (doi:10.1007/s00268-002-6667-z)
28. Roizen MF, Hunt TK, Beaupre PN, Kremer P, Firmin R, Chang CN, Alpert RA, Thomas CJ, Tyrrell JB & Cahalan MK. The effect of alpha-adrenergic blockade on cardiac performance and tissue oxygen delivery during excision of pheochromocytoma. Surgery 1983 94 941-945. (Pubitemid 14208783)
29. Steinsapir J, Carr AA, Prisant LM & Bransome ED Jr. Metyrosine and pheochromocytoma. Archives of Internal Medicine 1997 157 901-906. (doi:10.1001/archinte.157.8.901)
30. Ulchaker JC, Goldfarb DA, Bravo EL & Novick AC. Successful outcomes in pheochromocytoma surgery in the modern era. Journal of Urology 1999 161 764-767. (doi:10.1016/S0022-5347(01)61762-2)
31. Lentschener C, Gaujoux S, Thillois JM, Duboc D, Bertherat J, Ozier Y & Dousset B. Increased arterial pressure is not predictive of haemodynamic instability in patients undergoing adrenalectomy for phaeochromocytoma. Acta Anaesthesiologica Scandinavica 2009 53 522-527. (doi:10.1111/j.1399-6576.2008. 01894.x)
32. Kinney MA, Narr BJ & Warner MA. Perioperative management of pheochromocytoma. Journal of Cardiothoracic and Vascular Anesthesia 2002 16 359-369. (doi:10.1053/jcan.2002.124150)
33. Newell KA, Prinz RA, Brooks MH, Glisson SN, Barbato AL &Freark RJ. Plasma catecholamine changes during excision of pheochromocytoma. Surgery 1988 104 1064-1073. (Pubitemid 19011987)
34. Boutros AR, Bravo EL, Zanettin G & Straffon RA. Perioperative management of 63 patients with pheochromocytoma. Cleveland Clinic Journal of Medicine 1990 57 613-617. (Pubitemid 20360347)
35. Sjoerdsma A, Engelman K, Waldmann TA, Cooperman LH &Hammond WG. Pheochromocytoma: current concepts of diagnosis and treatment: Combined Clinical Staff Conference at the National Institutes of Health. Annals of Internal Medicine 1966 65 1302-1326.
36. Finnerty FA Jr, Buchholz JH & Guillaudeu RL. The blood volumes and plasma protein during levarterenol-induced hypertension. Journal of Clinical Investigation 1958 37 425-429. (doi:10.1172/JCI103622)
37. Yanagawa Y, Sakamoto T & Okada Y. Hypovolemic shock evaluated by sonographic measurement of the inferior vena cava during resuscitation in trauma patients. Journal of Trauma 2007 63 1245-1248. (doi:10.1097/TA. 0b013e318068d72b)
38. Mallat J, Pironkov A, Destandau MS & Tavernier B. Systolic pressure variation (Deltadown) can guide fluid therapy during pheochromocytoma surgery. Canadian Journal of Anaesthesia 2003 50 998-1003. (doi:10.1007/BF03018362)
39. Mercier FJ, Riley ET, Frederickson WL, Roger-Christoph S, Benhamou D & Cohen SE. Phenylephrine added to prophylactic ephedrine infusion during spinal anesthesia for elective cesarean section. Anesthesiology 2001 95 668-674. (doi:10.1097/00000542-200109000-00020)
40. McMillian WD, Trombley BJ, Charash WE & Christian RC. Phentolamine continuous infusion in a patient with pheochromocytoma. American Journal of Health-System Pharmacy 2011 68 130-134. (doi:10.2146/ajhp090619)
41. Witteles RM, Kaplan EL & Roizen MF. Safe and cost-effective preoperative preparation of patients with pheochromocytoma. Anesthesia and Analgesia 2000 91 302-304. (doi:10.1097/00000539-200008000-00011)
42. Halpern NA, Goldberg M, Neely C, Sladen RN, Goldberg JS, Floyd J, Gabrielson G & Greenstein RJ. Postoperative hypertension: a multicenter, prospective, randomized comparison between intravenous nicardipine and sodium nitroprusside. Critical Care Medicine 1992 20 1637-1643. (doi:10.1097/00003246- 199212000-00006)
43. Sibal L, Jovanovic A, Agarwal SC, Peaston RT, James RA, Lennard TW, Bliss R, Batchelor A & Perros P. Phaeochromocytomas presenting as acute crises after beta blockade therapy. Clinical Endocrinology 2006 65 186-190. (doi:10.1111/j.1365-2265.2006.02571.x)
44. Papadopoulos DP, Mourouzis I, Thomopoulos C, Makris T &Papademetriou V. Hypertension crisis. Blood Pressure 2010 19 328-336. (doi:10.3109/08037051. 2010.488052)
45. Engelman K, Jéquier E, Udenfriend S & Sjoerdsma A. Metabolism of alpha-methyltyrosine in man: relationship to its potency as an inhibitor of catecholamine biosynthesis. Journal of Clinical Investigation 1968 47 568-576. (doi:10.1172/JCI105753)
46. Tcherdakoff P, Menard J, Bedrossian J, Vaysse J, Alexandre JM, Desmonts JM & Milliez P. Alpha-methyl -para-tyrosine in the prolonged treatment of malignant pheochromocytoma and preoperative care of benign pheochromocytoma: preliminary study. Journal of Urology and Nephrology 1972 78 744-747.
47. Bruynzeel H, Feelders RA, Groenland TH, van den Meiracker AH, van Eijck CH, Lange JF, de Herder WW & Kazemier G. Risk factors for hemodynamic instability during surgery for pheochromocytoma. Journal of Clinical Endocrinology and Metabolism 2010 95 678-685. (doi:10.1210/jc.2009-1051)
48. Oliva R, Angelos P, Kaplan E & Bakris G. Pheochromocytoma in pregnancy: a case series and review. Hypertension 2010 55 600-606. (doi:10.1161/HYPERTENSIONAHA.109.147579)
49. Sarathi V, Lila A, Bandgar T, Menon P & Shah N. Pheochromocytoma and pregnancy: a rare but dangerous combination. Endocrine Practice 2009 26 1-21.
50. Joris JL, Hamoir EE, Hartstein GM, Meurisse MR, Hubert BM, Charlier CJ & Lamy ML. Hemodynamic changes and catecholamine release during laparoscopic adrenalectomy for pheochromocytoma. Anesthesia and Analgesia 1999 88 16-21. (doi:10.1097/00000539-199901000-00004)
51. Myles PS, Leslie K, McNeil J, Forbes A & Chan MT. Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. Lancet 2004 363 1757-1763. (doi:10.1016/S0140-6736(04)16300-9)
52. Lavery GG, Clarke RS & Watkins J. Histaminoid responses to atracurium, vecuronium and tubocurarine. Annales Françaises d'Anesthésie-Réanimation 1985 4 180-183. (doi:10.1016/S0750- 7658(85)80196-9)
53. Marik PE, Cavallazzi R, Vasu T & Hirani A. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients. A systematic review of the literature. Critical Care Medicine 2009 37 2642-2647. (doi:10.1097/CCM.0b013e3181a590da)
54. Monnet X, Rienzo M, Osman D, Anguel N, Richard C, Pinsky MR & Teboul JL. Esophageal Doppler monitoring predicts fluid responsiveness in critically ill ventilated patients. Intensive Care Medicine 2005 31 1195-1201. (doi:10.1007/s00134-005-2731-0)
55. Axler O, Megarbane B, Lentschener C & Fernandez H. Comparison of cardiac output measured with echocardiographic volumes and aortic Doppler methods during mechanical ventilation. Intensive Care Medicine 2003 29 208-217. (doi:10.1007/s00134-002-1582-1)
56. Friederich JA & Butterworth JF IV. Sodium nitroprusside: twenty years and counting. Anesthesia and Analgesia 1995 81 152-162. (doi:10.1097/00000539- 199507000-00031)
57. AbdelDayem TM, El-Mawardy R, Abdel-Dayem MK, Rayan M, El-Mahmoudy A, Shawky G & Nammas W. Assessment of coronary flow parameters by transesophageal echocardiography in patients with isolated coronary artery ectasia: effect of intravenous nitroglycerin. Echocardiography 2010 27 1004-1010. (doi:10.1111/j.1540-8175.2010.01164.x)
58. Hamilton A, Sirrs S, Schmidt N & Onrot J. Anaesthesia for phaeochromocytoma in pregnancy. Canadian Journal of Anaesthesia 1997 44 654-657. (doi:10.1007/BF03015450)
59. Gray RJ. Managing critically ill patients with esmolol: an ultra short-acting b-adrenergic blocker. Chest 1988 93 398-403. (doi:10.1378/chest.93. 2.398)
60. Weismann D, Fassnacht M, Weinberger F, Hamelmann W, Diehl S, Lorenz K, Baerlehner E, Reincke M, Beuschlein F, Knoefel W, Nies C, Hahner S & Allolio B. Intraoperative haemodynamic stability in patients with phaeochromocytoma - minimally invasive vs conventional open surgery. Clinical Endocrinology 2006 65 352-358. (doi:10.1111/j.1365-2265.2006.02603.x)
61. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A & Goldman L. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999 100 1043-1049. (doi:10.1161/01.CIR.100.10.1043)
62. Roizen MF. Anesthetic implications of concurrent diseases. In Anesthesia, edn 5, pp 903-1015. Ed. RD Miller, Philadelphia: Churchill Livingstone, 2000.
63. Howell SJ, Sear YM, Yeates D, Goldacre M, Sear JW & Foe¨x P. Risk factors for cardiovascular death after elective surgery under general anaesthesia. British Journal of Anaesthesia 1998 80 14-19. (doi:10.1093/bja/80. 1.14)